[1] Haidong W, Mohsen N, Christine A, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015[J]. Lancet, 2016, 388(10053): 1459-1544.
[2] Chen WQ, Zheng RS, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[3] Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 134.
[4] Carbajo-Pescador S, Ordonez R, Benet M, et al. Inhibition of VEGF expression through blockade of Hif1alpha and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells[J]. Br J Cancer, 2013, 109(1): 83-91.
[5] Goradel NH, Asghari MH, Moloudizargari M, et al. Melatonin as an angiogenesis inhibitor to combat cancer: mechanistic evidence[J]. Toxicol Appl Pharmacol, 2017,335(21):56-63.
[6] Radogna F, Diederich M, Ghibelli L. Melatonin: a pleiotropic molecule regulating inflammol/Lation[J]. Biochem Pharmacol, 2010, 80(12): 1844-1852.
[7] Muc-Wierzgon M, Nowakowska ZE, Zubelewicz B, et al. Circadian fluctuations of melatonin, tumor necrosis factor-alpha and its soluble receptors in the Circulation of patients with advanced gastrointestinal cancer[J].J Exp Clin Cancer Res,2003, 22(2): 171-178.
[8] Cardinali DP,Cano P,Jiménez-Ortega V, et al. Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications[J]. Neuroendocrinology, 2011,93(3):133-142.
[9] Zou ZW,Liu T,Li Y, et al. Melatonin suppresses thyroid cancer growth and overcomes radioresistance via inhibition of p65 phosphorylation and induction of ROS[J]. Redox Biol,2018,16(6):226-236.
[10] Kubatka P, Zubor P, Busselberg D, et al. Melatonin and breast cancer: evidences from preclinical and human studies[J]. Crit Rev Oncol Hematol,2018,122 (2):133-143.
[11] Shen CJ, Chang CC, Chen YT,et al. Melatonin suppresses the growth of ovarian cancer cell lines (OVCAR-429 and PA-1) and potentiates the effect of G1 arrest by targeting CDKs[J]. Int J Mol Sci, 2016,17(2): 176-187.
[12] Asghari MH, Moloudizargari M, Ghobadi E, et al. Melatonin as a multifunctional anti-cancer molecule: implications in gastric cancer[J]. Life Sci, 2017,185(31):38-45.
[13] Liu H, Jiang JH, Xu L, et al. Effect of melatonin on proliferation inhibition and apoptosis induction in the murine foregastric carcinoma cell in vivo and in vitro[J]. Acta Anatomica Sinica, 2011,42(6):792-797. (in Chinese)
刘卉,蒋继浩,徐丽,等. 褪黑素体内外对小鼠前胃癌细胞的增殖抑制与凋亡诱导作用[J].解剖学报,2011,42(6):792-797.
[14] Zhou MX, Tu JR. Correlation analysis of IL-2, IL-10 and their sensitivity to chemoradiation in patients with nasopharyngeal carcinoma[J]. Journal of Practical Cancer, 2017, 32(4): 598-602. (in Chinese)
周美秀,涂建仁. 鼻咽癌外周血IL-2,IL-10水平与其放化疗敏感性的相关性分析[J]. 实用癌症杂志, 2017, 32(4): 598-602.
[15] Yi X,Tang AZh, Qin Y. Detection of IL -10 and IL -12 in the patients with nasopharyngeal carcinoma[J]. Chinese Journal of Moder n Medicine, 2009, 11(8): 46-48. (in Chinese)
易翔,唐安洲,覃颖. 鼻咽癌中白细胞介素-10,白细胞介素-12检测及其意义[J]. 中国现代医药杂志, 2009, 11(8): 46-48.
[16] Khaghanzadeh N, Samiei A, Ramezani M, et al. Umbelliprenin induced production of INF-γ and TNF-α, and reduced IL-10, IL-4, Foxp3 and TGF-β in a mouse model of lung cancer[J]. Immunopharmacol Immunotoxicol, 2014, 36(1): 25-32.
[17] Abiko K, Matsumura N, Hamanishi J, et al. INF-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer[J]. Br J Cancer, 2015, 112(9): 1501-1509.
|